Slide The Rabin Cone Contrast Test detects changes associated with eye and Neurological diseases and reducing the overall cost of healthcare. Further aiding in eyesight preservation,

Sensitive enough to detect the severity of cone deficiency

Can determine hereditary and acquired color deficiency in a single test

Used to detect and monitor acquired color deficiency in eye disease and poor retinal health


Custom Calibration


Calibrated for color and contrast


Detects sub-standard monitors and end-of-life color meters


Scheduled in-field calibration adapts to clinic or research


Ensures validity and repeatability of results


Comparisons detect significant changes in cone function:


Color Normals vs. Color Deficients

Acquired Color Deficiency in Central Serous Retinopathy:


Blue (Tritan)

Slide Patient Benefits Identification of patients at-risk for developing disease Earlier recognition and intervention of disease Rapid detection of disease progression Evaluation of treatment efficacy Improved Quality of Care Slide Financial Benefits Increases Medicare billings for 92283

Extended Color Vision Exam
Drives Medicare billings of structural

diagnostic equipment
Increases clinic economic throughput

by identifying patients most in need of care
Increased Per-Patient Revenue